Anna Pierce
Learn more about the people at Monash Infectious Diseases.
Anna Pierce
email
MBBS (Hons) (Monash) FRACP GradDipClinEpi (Monash)
Infectious Diseases Physician
Also
Infectious Diseases Physician, Alfred Hospital
Physician, Victorian Non-Occupational Post Exposure Prophylaxis (NPEP) Service
Professional Roles
2004 Clinical Sub-editor, Australasian Society for HIV Medicine Journal Club
2001 Organising Committee, Australasian Society for HIV Medicine Annual Conference
Publications
Book Chapters
Pierce AB, Zablotska I.
Biomedical prevention of HIV
HIV Management in Australasia. A Guide for Clinical Care
Australasian Society for HIV Medicine, 2017
Antiretroviral therapy.
Pett S, Pierce A.
In: Hoy J. Lewin SR. Post JJ. Street A. (eds).
HIV Management in Australasia: A Guide for Clinical Care, Australasian Society for HIV Medicine, 2009.
Monitoring, adherence and therapeutic failure.
Vujovic O, Pierce A.
In: Hoy J. Lewin SR. Post JJ. Street A. (eds).
HIV Management in Australasia: A Guide for Clinical Care, Australasian Society for HIV Medicine, 2009.
Strategies to improve treatment outcome.
Pett S, Pierce A.
In: Hoy J. Lewin SR. Post JJ. Street A. (eds).
HIV Management in Australasia: A Guide for Clinical Care, Australasian Society for HIV Medicine, 2009.
Post-exposure prophylaxis.
Pierce A.
In: Hoy J. Lewin SR. Post JJ. Street A. (eds).
HIV Management in Australasia: A Guide for Clinical Care, Australasian Society for HIV Medicine, 2009.
Journal articles
Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance system.
Pierce AB, El-Hayek C, McCarthy D, Armishaw J, Watson K, Wilkinson A, Price B, Wright EJ, Hoy JF, Stoové MA.
Sex Health. 2017 Apr;14(2):179-187. doi: 10.1071/SH16132.
PMID: 27914484
Dolutegravir with tenofovir disoproxil fumarate – emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men.
Mcallister J, Towns JM, Mcnulty A, Pierce AB, Foster R, Richardson R, Carr A.
AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001447. [Epub ahead of print]
PMID: 28301425
Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance system.
Pierce AB, El-Hayek C, McCarthy D, Armishaw J, Watson K, Wilkinson A, Price B, Wright EJ, Hoy JF, Stoové MA.
Sex Health. 2016 Dec 5. doi: 10.1071/SH16132. [Epub ahead of print]
PMID: 27914484
Single-tablet emtricitabine-rilpivirine-tenofovir as HIV post-exposure prophylaxis in men who have sex with men.
Foster R, McAllister J, Read TR, Pierce AB, Richardson R, McNulty A, Carr A.
Clin Infect Dis. 2015 Oct 15;61(8):1336-41. doi: 10.1093/cid/civ511.
PMID: 26123937
Developing an evidence-based guideline for the management of exposure to hepatitis B at a Victorian tertiary hospital.
Pierce AB, Armishaw J, Aitchison S.
Aust N Z J Public Health. 2013 Oct;37(5):411-5. doi: 10.1111/1753-6405.12107.
PMID: 24090322 [PubMed – in process]
Inhibition of telomerase activity by HIV Nucleos(t)ide Reverse Transcriptase Inhibitors: a potential factor contributing to HIV-associated accelerated ageing.
Leeansyah E, Cameron PU, Solomon A, Tennakoon S, Velayudham P, Gouillou M, Spelman T, Hearps A, Fairley C, Smit DV, Pierce AB, Armishaw J, Crowe SM, Cooper DA, Koelsch KK, Liu JP, Chuah J, Lewin SR.
J Infect Dis. 2013 Apr;207(7):1157-65. doi: 10.1093/infdis/jit006. Epub 2013 Jan 9.
PMID: 23303810 [PubMed – indexed for MEDLINE]
Adherence to HIV treatment guidelines for comorbid disease assessment and initiation of antiretroviral therapy.
Bloch M, Hoy J, Cunningham N, Roth N, Bailey M, Pierce A, Watson J, Carr A.
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):478-88.
PMID: 22367456 [PubMed – indexed for MEDLINE]
Nonoccupational post-exposure prophylaxis source tracing: is it really feasible in Australia?
Pierce AB, Armishaw J, Price B, Wright EJ, Dax EM, Fairley CK, Hoy JF.
HIV Med. 2012 Aug;13(7):436-8. doi: 10.1111/j.1468-1293.2011.00986.x. Epub 2012 Jan 25.
PMID: 22276852 [PubMed – indexed for MEDLINE]
Non-occupational post-exposure prophylaxis in Victoria, Australia: responding to high rates of re-presentation and low rates of follow-up.
Armishaw J, Hoy JF, Watson KM, Wright EJ, Price BG, Pierce AB.
Int J STD AIDS. 2011 Dec;22(12):714-8.
PMID: 22174051 [PubMed – indexed for MEDLINE]
HIV seroconversions among male non-occupational post-exposure prophylaxis service users: a data linkage study.
Pierce AB, Yohannes K, Guy R, Watson KM, Armishaw J, Price B, Hoy JF, Wright EJ, Stoové MA.
Sex Health. 2011 Jun;8(2):179-83.
PMID: 21592431 [PubMed – in process]
Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia.
Guinot D, Ho MT, Poynten IM, McAllister J, Pierce A, Pell C, Grulich AE.
HIV Med. 2009 Apr;10(4):199-208. Epub 2009 Jan 22.
Leber’s hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus.
Mackey DA, Fingert JH, Luzhansky JZ, McCluskey PJ, Howell N, Hall AJ, Pierce AB, Hoy JF.
Eye (Lond). 2003 Apr;17(3):312-7.
PMID: 12724691 [PubMed – indexed for MEDLINE]
Is the recommendation for pneumococcal vaccination of HIV patients evidence based?
Pierce AB, Hoy JF.
J Clin Virol. 2001 Oct;22(3):255-61.
PMID: 11564590 [PubMed – indexed for MEDLINE]
Leber’s hereditary optic neuropathy in the setting of nucleoside analogue toxicity.
Luzhansky JZ, Pierce AB, Hoy JF, Hall AJ.
AIDS. 2001 Aug 17;15(12):1588-9. No abstract available.
PMID: 11504997 [PubMed – indexed for MEDLINE]
Routine vaccinations for HIV-1 infected adults.
Kent SJ, Pierce AB.
Australasian Society for HIV Medicine position paper 2001.
Vibrio cholerae in Victoria.
Pierce AB, Broughton SJ, Johnson PD, Grayson ML.
Med J Aust. 2000 Jan 3;172(1):44, 46. No abstract available.
PMID: 10682025 [PubMed – indexed for MEDLINE